Skip to main content
SpringerLink
Log in

Les sarcomes des parties molles

  • Chapter
Thérapeutique du cancer

  • 766 Accesses

Résumé

Sous le vocable de sarcome des parties molles, on regroupe une grande variété de tumeurs malignes dont la différentiation exprime le plus souvent des analogies avec les tissus d’origine mésodermique ou plus rarement ectodermique (sarcome des gaines nerveuses périphériques ou sarcome d’Ewing extrasquelettique). On soupçonne que les sarcomes proviennent soit de cellules souches, qui correspondraient alors aux sarcomes indifférenciés, ou de cellules de lignées plus différentiées donnant alors des caractères reconnaissables de tissus adipeux, musculaire lisse, nerveux, etc. [1].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. Toguchida J, Nakayama T (2009) Molecular genetics of sarcomas: applications to diagnoses and therapy. Cancer Sci 100: 1573–1580

    Article  PubMed  CAS  Google Scholar 

  2. Angervall L, Kindblom LG (1993) Principles for Pathological-Anatomic Diagnosis and Classification of soft-tissue sarcomas. Clin Orthop 289: 9–18

    PubMed  Google Scholar 

  3. Cordon-Cardo C, Brennan MF, Casper ES et al. (1997) Sarcomas of the soft tissue and bone. In: Cancer Principles and Practice of Oncology. Ed. Lippincott-Raven Publishers 5: p. 1731–1782

    Google Scholar 

  4. Taghian A, de Vathaire F, Terrier P et al. (1991) Long-term risk of sarcoma following radiation treatment for breast cancer. Int J Radiat Oncol Biol Phys 21: 361–367

    Article  PubMed  CAS  Google Scholar 

  5. Penel N, Grosjean J, Robin YM et al. (2008) Frequency of certain established risk factors in soft tissue sarcomas in adults: a prospective descriptive study of 658 cases. Sarcoma p.1–6

    Google Scholar 

  6. Weiss SW, Goldblum JR (ed) Enzinger and Weiss’s Soft Tissue Tumors (2008) Mosby Elsevier, New York

    Google Scholar 

  7. Bovée JV, Hogendoorn PC (2009) Molecular pathology of sarcomas: concepts and clinical implications. Virchows Arch Sep 29. [Epub ahead of print]

    Google Scholar 

  8. Riad S, Griffin AM, Liberman B et al. (2004) Lymph node metastasis in soft tissue sarcoma in an extremity. Clin Orthop Relat Res 426: 129–134

    Article  PubMed  Google Scholar 

  9. Scarborough MT (2004) The biopsy. Instr Course Lect 53: 635–644

    Google Scholar 

  10. Charest M, Hickeson M, Lisbona R et al. (2009) FDG PET-CT imaging in primary osseous and soft tissue sarcomas — A retrospective review of 212 cases. Eur J Nucl Med Mol Imaging 36: 1944–1951

    Article  PubMed  Google Scholar 

  11. Soft tissues (2009) In: Sobin L, Gospodarowicz, Wittekind C (eds) International Union Against Cancer: TNM classification of malignant tumors. 7th ed. Oxford: Wiley-Blackwell, p.157–161

    Google Scholar 

  12. Kattan MW, Leung DH, Brennan MF (2002) Postoperative nomogram for 12-year sarcoma-specific death. J Clin Oncol 20: 791–796

    Article  PubMed  Google Scholar 

  13. Eilber FC, Brennan MF, Eilber FR et al. (2004) Validation of the postoperative nomogram for 12-year sarcoma-specific mortality. Cancer 101: 2270–2275

    Article  PubMed  Google Scholar 

  14. Mariani L, Miceli R, Kattan MW et al. (2005) Validation and adaptation of a nomogram for predicting the survival of patients with extremity soft tissue sarcoma using a three-grade system. Cancer 103: 402–408

    Article  PubMed  Google Scholar 

  15. Tepper JE, Suit HD (1985) Radiation therapy alone for sarcoma of soft tissue. Cancer 56: 475–479

    Article  PubMed  CAS  Google Scholar 

  16. White LM, Wunder JS, Bell RS et al. (2005) Histologic assessment of peritumoral edema in soft tissue sarcoma. Int J Radiat Oncol Biol Phys 61: 1439–1445

    Article  PubMed  Google Scholar 

  17. Gerrand CH, Wunder JS, Kandel RA et al. (2001) Classification of positive margins after resection of soft-tissue sarcoma of the limb predicts the risk of local recurrence. J Bone Joint Surg Br 83: 1149–1155

    Article  PubMed  CAS  Google Scholar 

  18. Jones KB, Ferguson PC, Deheshi B et al. (2009) Complete Femoral Nerve Resection with Soft Tissue Sarcoma: Functional Outcomes. Ann Surg Oncol 17: 401–406

    Article  PubMed  Google Scholar 

  19. Mahendra A, Gortzak Y, Ferguson PC et al. (2009) Management of vascular involvement in extremity soft tissue sarcoma. Recent Results Cancer Res 179: 285–299

    Article  PubMed  Google Scholar 

  20. Ferguson PC, Kulidjian AA, Jones KB et al. (2009) Peripheral nerve considerations in the management of extremity soft tissue sarcomas. Recent Results Cancer Res 179: 243–256

    Article  PubMed  Google Scholar 

  21. Ferguson PC, Griffin AM, O’Sullivan B et al. (2006) Bone invasion in extremity soft-tissue sarcoma: impact on disease outcomes. Cancer 106: 2692–2700

    Article  PubMed  Google Scholar 

  22. Hoekstra HJ (2008) Extremity perfusion for sarcoma. Surg Oncol Clin N Am Oct 17: 805–824

    Article  Google Scholar 

  23. Bonvalot S, Rimareix F, Causeret S et al. (2009) Hyperthermic Isolated Limb Perfusion in Locally Advanced Soft Tissue Sarcoma and Progressive Desmoid-Type Fibromatosis with TNF 1 mg and Melphalan (T1-M HILP) Is Safe and Efficient. Ann Surg Oncol 16: 3350–3357

    Article  PubMed  Google Scholar 

  24. Olieman AF, Pras E, van Ginkel RJ et al. (1998) Feasibility and efficacy of external beam radiotherapy after hyperthermic isolated limb perfusion with TNF-alpha and melphalan for limb-saving treatment in locally advanced extremity soft-tissue sarcoma. Int J Radiat Oncol Biol Phys 40: 807–814

    Article  PubMed  CAS  Google Scholar 

  25. Stoeckle E, Coindre JM, Bonvalot S et al. (2001) Prognostic factors in retroperitoneal sarcoma: a multivariate analysis of a series of 165 patients of the French Cancer Center Federation Sarcoma Group. Cancer 92: 359–368

    Article  PubMed  CAS  Google Scholar 

  26. Trovik CS, Bauer HC (1999) Local recurrence after surgery for soft tissue sarcoma. The Scandinavian Sarcoma Group experience. Acta Orthop Scand 285: 45–46

    CAS  Google Scholar 

  27. Rosenberg SA, Tepper J, Glatstein E et al. (1982) The treatment of soft-tissue sarcomas of the extremities: prospective randomized evaluations of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy. Ann Surg 196: 305–315

    Article  PubMed  CAS  Google Scholar 

  28. Yang JC, Chang AE, Baker AR et al. (1998) Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol 16: 197–203

    PubMed  CAS  Google Scholar 

  29. Pisters PW, Harrison LB, Leung DH et al. (1996) Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. J Clin Oncol 14: 859–868

    PubMed  CAS  Google Scholar 

  30. Pisters PW, Pollock RE, Lewis VO et al. (2007) Long-term results of prospective trial of surgery alone with selective use of radiation for patients with T1 extremity and trunk soft tissue sarcomas. Ann Surg 246: 675–681; discussion 681–672

    Article  PubMed  Google Scholar 

  31. Rydholm A, Gustafson P, Rooser B et al. (1991) Subcutaneous sarcoma. A population-based study of 129 patients. J Bone Joint Surg Br 73: 662–667

    PubMed  CAS  Google Scholar 

  32. Davis AM, O’Sullivan B, Bell RS et al. (2002) Function and health status outcomes in a randomized trial comparing preoperative and postoperative radiotherapy in extremity soft tissue sarcoma. J Clin Oncol 20: 4472–4477

    Article  PubMed  CAS  Google Scholar 

  33. Dickie CI, Parent AL, Griffin AM et al. (2009) Bone fractures following external beam radiotherapy and limb-preservation surgery for lower extremity soft tissue sarcoma: relationship to irradiated bone length, volume, tumor location and dose. Int J Radiat Oncol Biol Phys 75: 1119–1124

    Article  PubMed  Google Scholar 

  34. Holt GE, Griffin AM, Pintilie M et al. (2005) Fractures following radiotherapy and limb-salvage surgery for lower extremity soft-tissue sarcomas. A comparison of high-dose and low-dose radiotherapy. J Bone Joint Surg Am 87: 315–319

    Article  PubMed  Google Scholar 

  35. Griffin, AM, Euler CI, Sharpe MB et al. (2007) Radiation planning comparison for superficial tissue avoidance in radiotherapy for soft tissue sarcoma of the lower extremity. Int J Radiat Oncol Biol Phys 67: 847–856

    Article  PubMed  Google Scholar 

  36. Lehnert T, Cardona S, Hinz U et al. (2009) Primary and locally recurrent retroperitoneal soft-tissue sarcoma: Local control and survival. Eur J Surg Oncol 35: 986–993

    Article  PubMed  CAS  Google Scholar 

  37. Ballo MT, Zagars GK, Pollock RE et al. (2007) Retroperitoneal soft tissue sarcoma: an analysis of radiation and surgical treatment. Int J Radiat Oncol Biol Phys 67: 158–163

    Article  PubMed  Google Scholar 

  38. Le Pechoux C, Pautier P, Delannes M et al. (2006) [Clinical practice guidelines: 2006 update of recommendations for the radiotherapeutic management of patients with soft tissue sarcoma (sarcoma of the extremity, uterine sarcoma and retroperitoneal sarcoma]. Cancer Radiother 10: 185–207

    Article  PubMed  Google Scholar 

  39. Sindelar WF, Kinsella TJ, Chen PW et al. (1993) Intraoperative radiotherapy in retroperitoneal sarcomas. Final results of a prospective, randomized, clinical trial. Arch Surg 128: 402–410

    Article  PubMed  CAS  Google Scholar 

  40. Sarcoma Meta-analysis Collaboration (1997) Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data. Sarcoma Meta-analysis Collaboration. Lancet 350: 1647–1654

    Article  Google Scholar 

  41. Le Cesne A, Van Glabbeke M, Woll PJ et al. (2008) The end of adjuvant chemotherapy era with doxorubicin-based regimen in resected high-grade soft tissue sarcoma: Pooled analysis of the two STBSG-EORTC phase III clinical trials (abstract). J Clin Oncol 26: 559s

    Google Scholar 

  42. Eilber FC; Rosen G; Eckardt J et al. (2001) Treatment-induced pathologic necrosis: a predictor of local recurrence and survival in patients receiving neoadjuvant therapy for high-grade extremity soft tissue sarcomas. J Clin Oncol 19: 3203–3209

    PubMed  CAS  Google Scholar 

  43. Lucas DR, Kshirsagar MP, Biermann JS et al. (2008) Histologic alterations from neoadjuvant chemotherapy in high-grade extremity soft tissue sarcoma: clinicopathological correlation. Oncologist 13: 451–458

    Article  PubMed  Google Scholar 

  44. Clark MA, Fisher C, Judson I, Thomas JM (2005) Soft-Tissue Sarcomas in Adults. N Engl J Med 353: 701–711

    Article  PubMed  CAS  Google Scholar 

  45. Blanke CD, Demetri G, von Mehren M et al. (2008) Long-term results from a randomized phase II trial of standard-versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT. J Clin Oncol 26: 620–625

    Article  PubMed  CAS  Google Scholar 

  46. Fleming JB, Cantor SB, Varma DG et al. (2001) Utility of chest computed tomography for staging in patients with T1 extremity soft tissue sarcomas. Cancer 92: 863–868

    Article  PubMed  CAS  Google Scholar 

  47. Judson I, Radford JA, Harris M et al. (2001) Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL/CAELYX) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group. Eur J Cancer 37: 870–877

    Article  PubMed  CAS  Google Scholar 

  48. Brennan MF, Casper ES, Harrison LB (2002) Soft tissue sarcoma. In: Devita VT, Hellman S, Rosenberg SA (eds) Cancer: Principles and Practice of Oncology, Sixth Edition. Lippinocott-Raven Publishers, Philadelphia, p. 1738–1887

    Google Scholar 

  49. Demetri GD, Chawla SP, von Mehren M et al. (2009) J Clin Oncol 27: 4188–4196. Epub 2009 Aug 3

    Article  PubMed  CAS  Google Scholar 

  50. Santoro A (1999) Advanced soft tissue sarcoma: how many more trials with anthracyclines and ifosfamide? Ann Oncol 10: 151–154

    Article  PubMed  CAS  Google Scholar 

  51. Hensley MH, Maki R, Venkatraman E et al. (2002) Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial. J Clin Oncol 12: 2824–2831

    Article  Google Scholar 

  52. Maki RG, Wathen JK, Patel SR et al. (2007) Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: results of sarcoma alliance for research through collaboration study 002 [corrected] J Clin Oncol 25(19): 2755–2763. Erratum in: J Clin Oncol 25 (24): 3790

    Article  PubMed  CAS  Google Scholar 

  53. Kasper B, Scharrenbroich I, Schmitt T et al. (2010) Consolidation with high-dose chemotherapy and stem cell support for responding patients with metastatic soft tissue sarcomas: prospective, single-institutional phase II study. Bone Marrow Transplant 45: 1234–1238

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Service de chirurgie orthopédique, Centre universitaire de santé McGill, 1650 avenue Cedar, Montréal, Québec, Canada, H3G 1A4

    R. Turcotte

  2. Service d’oncologie, Centre universitaire de santé McGill, 1650 avenue Cedar, Montréal, Québec, Canada, H3G 1A4

    T. Alcindor

  3. Service de radio-oncologie, Centre universitaire de santée McGill, 1650, avenue Cedar, Montréeal, Quéebec, Canada, H3G 1A4

    D. Roberge

Authors
  1. R. Turcotte
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T. Alcindor
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D. Roberge
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag France

About this chapter

Cite this chapter

Turcotte, R., Alcindor, T., Roberge, D. (2011). Les sarcomes des parties molles. In: Thérapeutique du cancer. Springer, Paris. https://doi.org/10.1007/978-2-8178-0021-9_36

Download citation

  • DOI: https://doi.org/10.1007/978-2-8178-0021-9_36

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-8178-0020-2

  • Online ISBN: 978-2-8178-0021-9

Publish with us

Policies and ethics

Search

Navigation